Search Results 161-170 of 1262 for ✈【광고문의:둘리알바】 원주노래방도우미알바 고성노래방도우미알바 횡성노래방도우미알바 원주노래방도우미알바✈

  1. Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension - Mayo Clinic

    This is a multicenter, randomized, double-blind, placebo-controlled trial involving subjects with NASH cirrhosis and severe portal hypertension (defined as HVPG ...

  2. A Study of the Effectiveness and Safety of Lubiprostone in Pediatric Patients with Functional Constipation - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. Smart Fabric for Cardio-Performance Enhancement - Mayo Clinic

    The aims of this study are to develop a smart fabric untethered compression garment to dynamically oppose orthostatic changes and that can be synchronized to ...

  4. Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. A Study to Evaluate if a Conversation Aid Will Help Patients and Clinicians in Discuss Diagnostic Testing - Mayo Clinic

    About this study. The purpose of this study is to determine whether a diagnostic reconciliation conversation aid can assist a shared decision making ...

  6. Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN) - Mayo Clinic

    About this study. The investigators goal is to evaluate the role of XOLAIR® in treatment of Acute Tubulointerstitial Nephritis (AIN) with the goal of ...

  7. rs7903146 genotype on islet GLP-1 production in humans - Mayo Clinic

    The purpose of this study is to determine the contribution of islet GLP-1 to islet function in people with and without diabetes-associated genetic variation in ...

  8. Efficacy and Safety of Lubiprostone in Pediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis - Mayo Clinic

    This is a multicenter, double-blind, randomized, placebo-controlled trial involving subjects with a diagnosis of "definite NASH" with fibrosis (excluding ...

  10. A Study to Investigate the Safety and Effectiveness of FE 999049 in Controlled Ovarian Stimulation in Women Aged 35-42 Years Old - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...